RxDoctor Payments Data

William Chesser, DO

Family Medicine · Konawa, OKNPI 1508959685

Payments from drug & device makers

$387in general payments, 2019–2025

Across 21 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$150
  • AbbVie$72
  • Pfizer$54
  • Lilly USA, LLC$33
  • Otsuka America Pharmaceutical, Inc.$31
  • Alkermes, Inc.$19
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 50th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$11,315
Medicare patients
172
Services billed
1,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab18$157,237
OzempicSemaglutide103$114,400
TrulicityDulaglutide92$113,658
EliquisApixaban78$83,198
FarxigaDapagliflozin Propanediol91$81,273
JardianceEmpagliflozin56$73,679
MounjaroTirzepatide51$58,628
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$28,248
MyrbetriqMirabegron24$26,245
JanuviaSitagliptin Phosphate23$23,628
TradjentaLinagliptin15$22,127
Xigduo XrDapaglifloz Propaned/Metformin24$19,120
Victoza 3-PakLiraglutide18$15,493
WegovySemaglutide11$14,342
RybelsusSemaglutide15$13,948

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$33$172,286143 claims
Novo NordiskOzempic, Wegovy, Rybelsus$15$142,690129 claims
PfizerEliquis$54$83,19878 claims
AbbVieQulipta, Linzess$72$24,24424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Konawa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →